West Pharmaceutical Services Common Stock Net 2010-2024 | WST

West Pharmaceutical Services common stock net from 2010 to 2024. Common stock net can be defined as the value of common equity ownership.
  • West Pharmaceutical Services common stock net for the quarter ending September 30, 2024 was $0.019B, a 0% increase year-over-year.
  • West Pharmaceutical Services common stock net for 2023 was $0.019B, a 0% decline from 2022.
  • West Pharmaceutical Services common stock net for 2022 was $0.019B, a 0% decline from 2021.
  • West Pharmaceutical Services common stock net for 2021 was $0.019B, a 0% decline from 2020.
West Pharmaceutical Services Annual Common Stock Net
(Millions of US $)
2023 $19
2022 $19
2021 $19
2020 $19
2019 $19
2018 $19
2017 $19
2016 $18
2015 $18
2014 $18
2013 $18
2012 $17
2011 $9
2010 $9
2009 $9
West Pharmaceutical Services Quarterly Common Stock Net
(Millions of US $)
2024-09-30 $19
2024-06-30 $19
2024-03-31 $19
2023-12-31 $19
2023-09-30 $19
2023-06-30 $19
2023-03-31 $19
2022-12-31 $19
2022-09-30 $19
2022-06-30 $19
2022-03-31 $19
2021-12-31 $19
2021-09-30 $19
2021-06-30 $19
2021-03-31 $19
2020-12-31 $19
2020-09-30 $19
2020-06-30 $19
2020-03-31 $19
2019-12-31 $19
2019-09-30 $19
2019-06-30 $19
2019-03-31 $19
2018-12-31 $19
2018-09-30 $19
2018-06-30 $19
2018-03-31 $19
2017-12-31 $19
2017-09-30 $19
2017-06-30 $19
2017-03-31 $19
2016-12-31 $18
2016-09-30 $18
2016-06-30 $18
2016-03-31 $18
2015-12-31 $18
2015-09-30 $18
2015-06-30 $18
2015-03-31 $18
2014-12-31 $18
2014-09-30 $18
2014-06-30 $18
2014-03-31 $18
2013-12-31 $18
2013-09-30 $18
2013-06-30 $9
2013-03-31 $9
2012-12-31 $17
2012-09-30 $9
2012-06-30 $9
2012-03-31 $9
2011-12-31 $9
2011-09-30 $9
2011-06-30 $9
2011-03-31 $9
2010-12-31 $9
2010-09-30 $9
2010-06-30 $9
2010-03-31 $9
2009-12-31 $9
2009-09-30 $9
2009-06-30 $9
2009-03-31 $9
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $23.723B $2.950B
West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical products in the Americas, Europe, the Middle East, Africa and the Asia Pacific. Its primary objective is to deliver quality products that cater to the exact product specifications and quality standards that customers expect and need. West Pharmaceutical operates through two segments: Proprietary Products and Contract-Manufactured Products.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $78.143B 21.32
Becton Dickinson (BDX) United States $67.812B 17.83
Cardinal Health (CAH) United States $29.438B 15.96
Cooper (COO) United States $20.623B 29.35
Labcorp (LH) United States $20.401B 16.92
Align Technology (ALGN) United States $16.815B 32.18
Henry Schein (HSIC) United States $8.514B 16.22
Merit Medical Systems (MMSI) United States $6.067B 30.98
DENTSPLY SIRONA (XRAY) United States $3.508B 9.54
CONMED (CNMD) United States $2.312B 19.29
Patterson (PDCO) United States $1.855B 9.79
STAAR Surgical (STAA) United States $1.499B 55.31
Lifevantage (LFVN) United States $0.176B 23.40
Pro-Dex (PDEX) United States $0.154B 30.74